ECSP045134A - Monohidrato de clorhidrato de venlafaxina y métodos para la preparación del mismo - Google Patents

Monohidrato de clorhidrato de venlafaxina y métodos para la preparación del mismo

Info

Publication number
ECSP045134A
ECSP045134A EC2004005134A ECSP045134A ECSP045134A EC SP045134 A ECSP045134 A EC SP045134A EC 2004005134 A EC2004005134 A EC 2004005134A EC SP045134 A ECSP045134 A EC SP045134A EC SP045134 A ECSP045134 A EC SP045134A
Authority
EC
Ecuador
Prior art keywords
methods
venlafaxine
monohidrate
chlorhydrate
preparation
Prior art date
Application number
EC2004005134A
Other languages
English (en)
Inventor
Jun Han
Yong Jai Lee
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP045134A publication Critical patent/ECSP045134A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención relaciona una forma polimórfico cristalino de clorhidrato de venlafaxina el cual existe en forma hidratada (por ejemplo, como un monohidrato), métodos para la preparación del mismo, y su uso.
EC2004005134A 2001-12-05 2004-06-04 Monohidrato de clorhidrato de venlafaxina y métodos para la preparación del mismo ECSP045134A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33582301P 2001-12-05 2001-12-05

Publications (1)

Publication Number Publication Date
ECSP045134A true ECSP045134A (es) 2004-07-23

Family

ID=23313363

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005134A ECSP045134A (es) 2001-12-05 2004-06-04 Monohidrato de clorhidrato de venlafaxina y métodos para la preparación del mismo

Country Status (20)

Country Link
US (2) US20030114536A1 (es)
EP (1) EP1451146A1 (es)
JP (1) JP2005511737A (es)
KR (1) KR20050044711A (es)
CN (1) CN1599715A (es)
AR (1) AR037636A1 (es)
AU (1) AU2002366574A1 (es)
BR (1) BR0214696A (es)
CA (1) CA2467614A1 (es)
CO (1) CO5580817A2 (es)
EC (1) ECSP045134A (es)
HU (1) HUP0402553A2 (es)
MX (1) MXPA04005307A (es)
NO (1) NO20042810L (es)
PL (1) PL370559A1 (es)
RU (1) RU2004120273A (es)
TW (1) TW200300669A (es)
UA (1) UA77234C2 (es)
WO (1) WO2003050076A1 (es)
ZA (1) ZA200405245B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005305A (es) * 2001-12-05 2004-09-13 Wyeth Corp Nuevo polimorfo cristalino de clorhidrato de venlafaxina y metodos para preparacion del mismo.
KR20070034129A (ko) * 2004-07-22 2007-03-27 와이어쓰 신경계 질환 및 장애의 치료 방법
EP1773321A2 (en) * 2004-07-22 2007-04-18 Wyeth Method for treating nervous system disorders and conditions
RU2007102292A (ru) * 2004-07-22 2008-08-27 Вайет (Us) Способ лечения расстройств и заболеваний нервной системы
WO2007047972A2 (en) * 2005-10-19 2007-04-26 Teva Pharmaceutical Industries Ltd. Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride
EP2436381A1 (en) 2006-06-27 2012-04-04 Sandoz AG Crystallization of hydrohalides of pharmaceutical compounds
DK2792662T3 (da) 2007-05-01 2016-07-25 Concert Pharmaceuticals Inc Morphinanforbindelser
US20120083487A1 (en) * 2008-10-30 2012-04-05 Amanda Thomas Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurolgical diseases, intractable and chronic pain and brain injury
WO2017040611A1 (en) * 2015-08-31 2017-03-09 Nutramax Laboratories, Inc. Compositions comprising magnolia, phellodendron, theanine and/or whey protein

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0639374T3 (da) * 1993-06-28 2002-05-06 American Home Prod Nye behandlingsmetoder ved anvendelse af phenethylderivater
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
US5506270A (en) * 1995-01-30 1996-04-09 American Home Products Corporation Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
AU2002241764A1 (en) * 2000-10-19 2002-06-18 Teva Pharmaceutical Industries Ltd. Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
CA2426393C (en) * 2000-10-31 2012-05-29 Ciba Specialty Chemicals Holding Inc. Crystalline forms of venlafaxine hydrochloride
WO2002046140A1 (en) * 2000-12-07 2002-06-13 Dr. Reddy's Laboratories Ltd. Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
TW200300669A (en) 2003-06-16
UA77234C2 (en) 2006-11-15
JP2005511737A (ja) 2005-04-28
AR037636A1 (es) 2004-11-17
NO20042810L (no) 2004-07-02
HUP0402553A2 (hu) 2005-03-29
CN1599715A (zh) 2005-03-23
KR20050044711A (ko) 2005-05-12
MXPA04005307A (es) 2004-09-13
BR0214696A (pt) 2004-11-03
PL370559A1 (en) 2005-05-30
AU2002366574A1 (en) 2003-06-23
RU2004120273A (ru) 2005-03-27
US20050272822A1 (en) 2005-12-08
CO5580817A2 (es) 2005-11-30
CA2467614A1 (en) 2003-06-19
ZA200405245B (en) 2007-01-31
EP1451146A1 (en) 2004-09-01
US20030114536A1 (en) 2003-06-19
WO2003050076A1 (en) 2003-06-19

Similar Documents

Publication Publication Date Title
TW200716512A (en) Processes for preparing cinacalcet hydrochloride crystal form I
NO20092611L (no) Krystallinsk faststoff Rasagilin base
IL186701A0 (en) C. perfringens alpha toxoid vaccine
PA8561301A1 (es) Moleculas pequenas para el tratamiento del crecimiento celular anormal
ITMI20052085A1 (it) Tutore ambidestro per polso provvisto di immobilizzatore del pollice
UY31758A (es) Forma cristalina anhidra de maleato de orvepitant
HN2006029142A (es) Proceso
GB2428042B (en) P gingivalis vaccine
AR058173A1 (es) Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas
MXPA04005307A (es) Clorhidrato de venlafaxina en forma de monohidrato y sus metodos de preparacion.
ITTO20040450A1 (it) Procedimento per la produzione di una sede di valvola.
ITMI20031144A0 (it) Analoghi del colchicoside
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
ITMI20041920A1 (it) Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina
ITTO20030850A1 (it) Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro.
BRPI0605901A (pt) formas polimórficas de maleato de tegaserode
ITMI20041941A1 (it) Processo per la preparazione di lisofosfatidilcoline
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
ITMI20040452A1 (it) Processo per la preparazione di oxcarbazepina
ITMI20051971A1 (it) Procedimento per la preparazione di - modafinil
ITMI20041086A1 (it) Procedimento per la preparazione di idrocarbilalogenuri
TW200640836A (en) Processes for preparing sertraline
ITMI20050278A1 (it) Procedimento per la preparazione del toremifene
ITMI20050892A1 (it) Procedimento per la preparazione di ossazolidin-2,4-dioni
ITMI20032069A1 (it) Procedimento per la preparazione di derivati benzilmidazolici.